
Nevro Corp. NVRO
Geschäftsbericht 2024
hinzugefügt 04.03.2025
Nevro Corp. EV/EBITDA 2011-2026 | NVRO
EV/EBITDA Jährlich Nevro Corp.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -23.6 | -101 | -48.4 | -41.4 | -90.9 | -118 | -25.5 | -6.97 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -6.97 | -118 | -57 |
EV/EBITDA anderer Aktien in der Medizinische Geräte
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Cutera
CUTR
|
-2.84 | - | -10.19 % | $ 1.99 M | ||
|
EDAP TMS S.A.
EDAP
|
-4.19 | - | - | $ 162 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
-1.06 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
1.65 | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
0.499 | - | - | $ 10.2 M | ||
|
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M | ||
|
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
-14.6 | $ 12.76 | -10.87 % | $ 361 M | ||
|
Apollo Endosurgery
APEN
|
-14 | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
-8.6 | $ 7.98 | 0.69 % | $ 1.2 B | ||
|
Aziyo Biologics
AZYO
|
0.0693 | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
-0.502 | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
-1.77 | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
-0.0908 | - | - | $ 16.4 M | ||
|
IRIDEX Corporation
IRIX
|
-17 | $ 1.11 | -3.91 % | $ 18.8 M | ||
|
Cardiovascular Systems
CSII
|
-19 | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
-16.5 | $ 1.22 | -12.86 % | $ 26.9 M | ||
|
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | ||
|
Cytosorbents Corporation
CTSO
|
-4.95 | $ 0.44 | -9.22 % | $ 27.4 M | ||
|
LivaNova PLC
LIVN
|
20.1 | $ 73.19 | -0.72 % | $ 3.99 B | ||
|
LENSAR
LNSR
|
-6.76 | $ 5.58 | -0.8 % | $ 66.7 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-165 | $ 18.35 | 1.38 % | $ 430 M | ||
|
Pulmonx Corporation
LUNG
|
-22.5 | $ 1.52 | -6.17 % | $ 61.8 M | ||
|
MiMedx Group
MDXG
|
-669 | $ 3.8 | 0.4 % | $ 562 M | ||
|
Delcath Systems
DCTH
|
329 | $ 10.66 | -1.25 % | $ 382 M | ||
|
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B | ||
|
Myomo
MYO
|
-3.47 | $ 1.25 | -2.35 % | $ 52.3 M | ||
|
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-20.6 | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
-2.59 | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
15.9 | $ 38.16 | 3.91 % | $ 323 M | ||
|
Profound Medical Corp.
PROF
|
-2.87 | $ 6.78 | -0.15 % | $ 205 M | ||
|
Butterfly Network
BFLY
|
-11.2 | $ 4.57 | -11.87 % | $ 1.13 B | ||
|
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
-0.274 | - | -0.97 % | $ 54.4 M | ||
|
Orthofix Medical
OFIX
|
31.1 | $ 10.42 | 0.77 % | $ 413 M | ||
|
GBS
GBS
|
-0.713 | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
16.8 | $ 81.01 | 1.26 % | $ 11 B | ||
|
Insulet Corporation
PODD
|
33.9 | $ 153.69 | 4.97 % | $ 10.8 B | ||
|
CONMED Corporation
CNMD
|
40.2 | $ 35.43 | 0.83 % | $ 1.1 B | ||
|
Sintx Technologies
SINT
|
-0.898 | $ 2.11 | -6.03 % | $ 5.85 M | ||
|
Inspire Medical Systems
INSP
|
-152 | $ 41.39 | -1.84 % | $ 1.22 B | ||
|
Integer Holdings Corporation
ITGR
|
18.2 | $ 92.64 | -0.02 % | $ 3.22 B | ||
|
Invacare Corporation
IVC
|
0.534 | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
34.7 | $ 85.71 | -1.97 % | $ 50.1 B |